Nanollose Ltd. (AU:NC6)
ASX:NC6
Want to see AU:NC6 full AI Analyst Report?
NC6 Stock Chart & Stats
AU$0.05
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.05
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.09
Previous CloseN/A
Volume1.00
Average Volume (3M)138.71K
Market Cap
AU$28.54M
Enterprise ValueAU$28.29M
Total Cash (Recent Filing)AU$274.97K
Total Debt (Recent Filing)AU$250.21K
Price to Earnings (P/E)―
Beta0.11
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding347,732,900
10 Day Avg. Volume179,263
30 Day Avg. Volume138,709
Financial Highlights & Ratios
PEG Ratio2.33
Price to Book (P/B)34.86
Price to Sales (P/S)0.00
P/FCF Ratio-12.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Sustainable Product PlatformNanollose’s microbial cellulose platform targets sustainable fibres and biomaterials, aligning with structural demand for low-impact textiles and nonwovens. A technology-based product moat can enable long-term market differentiation and multi-end-market revenue channels if commercial scale is achieved.
Low Financial LeverageLow debt reduces near-term solvency and interest burden, giving management flexibility to fund development through equity or grants rather than fixed obligations. This conserves operational optionality over months and lessens immediate default risk while technology commercialization proceeds.
Improving Free Cash Flow TrendAn improvement in free cash flow versus the prior year indicates partial operational progress or cost discipline. If sustained, this reduces external financing frequency, extends runway, and supports continued R&D and scale-up efforts—key for a development-stage materials business.
Bears Say
Persistent UnprofitabilityRepeated annual losses mean the company cannot self-fund growth from operating profits. Continued negative margins reduce reinvestment capacity, elevate dependence on external capital, and make long-term value creation contingent on a material turnaround in commercial traction.
Revenue Volatility And CollapseA collapse to zero reported revenue signals very limited or interrupted commercial traction, undermining prospects for predictable top-line scaling. Structural market entry and customer adoption risks are high, increasing the likelihood that R&D investments may not translate into sustainable revenues.
Weak Cash Generation; Financing RelianceConsistently negative operating and free cash flow indicates the business consumes cash to operate and develop products. Reliance on external financing raises dilution and execution risk, constraining long-term planning and potentially delaying commercialization milestones if capital access tightens.
Nanollose Ltd. News
NC6 FAQ
What was Nanollose Ltd.’s price range in the past 12 months?
Nanollose Ltd. lowest share price was AU$0.03 and its highest was AU$0.09 in the past 12 months.
What is Nanollose Ltd.’s market cap?
Nanollose Ltd.’s market cap is AU$28.54M.
When is Nanollose Ltd.’s upcoming earnings report date?
Nanollose Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 128 days.
How were Nanollose Ltd.’s earnings last quarter?
Nanollose Ltd. released its earnings results on Feb 26, 2026. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.
Is Nanollose Ltd. overvalued?
According to Wall Street analysts Nanollose Ltd.’s price is currently Overvalued.
Does Nanollose Ltd. pay dividends?
Nanollose Ltd. does not currently pay dividends.
What is Nanollose Ltd.’s EPS estimate?
Nanollose Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nanollose Ltd. have?
Nanollose Ltd. has 347,732,900 shares outstanding.
What happened to Nanollose Ltd.’s price movement after its last earnings report?
Nanollose Ltd. reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.389%.
Which hedge fund is a major shareholder of Nanollose Ltd.?
Currently, no hedge funds are holding shares in AU:NC6
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nanollose Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:NC6 Sentiment 83%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
188.88%
12-Months-Change
Fundamentals
Return on Equity
-1964.93%
Trailing 12-Months
Asset Growth
-23.63%
Trailing 12-Months
Company Description
Nanollose Ltd.
Nanollose Limited, a biomaterials company, engages in the research and development, and promotion of the microbial nanocellulose technology in Australia. The company offers Nullarbor Fibre, a tree-free Nullarbor lyocell fibre; and Jelli Grow, an alternative seed germination and plant growing material. Its products are used in textiles, nonwoven fabric, and other industries. The company was incorporated in 2014 and is based in Nedlands, Australia.
Technical Analysis
Prescient Therapeutics Limited
―
AnteoTech Ltd
―
Regeneus Ltd.
―
AdAlta Ltd.
―
Arovella Therapeutics Limited
―
Options Prices
Currently, No data available
---